temperature was taken from tympanic membrane bilaterally before and after MRI. If temperature change was more or les than 0.1 degrees celsius the patient was considered as warmer or cooler.
Effects of Propofol and Ketofol on Core Body Temperature in MRI
Brief Summary
Investigators researched the effect of two different types of drugs on core body temperature during magnetic resonance imaging. The hypothesis is in ketamine group, thermo disregulation is not as distinct as in propofol group, due to its positive effect on thermo regulation
Intervention / Treatment
-
Propofol (DRUG)propofol, midazolam and atropine administration via intravenous cannula.
-
Ketamine propofol mixture (DRUG)Administration of ketamine propofol mixture, midazolam and atropine via intravenous cannula
Condition or Disease
- Children
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Completed |
Study results: | No Results Available |
Age: | 6 Months to 10 Years |
Enrollment: | 90 (ACTUAL) |
Funded by: | Other |
Allocation: | Randomized |
Primary Purpose: | Supportive Care |
MaskingQUADRUPLE:
|
Clinical Trial Dates
Start date: | Aug 01, 2014 | |
---|---|---|
Primary Completion: | Feb 01, 2015 | ACTUAL |
Completion Date: | Feb 01, 2016 | ACTUAL |
Study First Posted: | Oct 13, 2016 | ESTIMATED |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Feb 16, 2018 |
Sponsors / Collaborators
Lead Sponsor:
Istanbul University
Responsible Party:
N/A
Intravenous anesthetics may impair thermoregulation. Absorption of radiofrequency waves by the body surface may result in heating, especially in small children during magnetic resonance imaging (MRI). Investigators applied two different intravenous anesthetics as propofol and ketamine and studied the effect of these drugs on core body temperature.
All patients aged between 6 months-10 years were administered midazolam and atropine. After that 1 mg/ kg of propofol was applied in group I, and 0,1 ml/kg of propofol ketamine mixture ( 10 mg/ml each) was applied in group II. Core body temperatures were taken before and after MRI and compared.
All patients aged between 6 months-10 years were administered midazolam and atropine. After that 1 mg/ kg of propofol was applied in group I, and 0,1 ml/kg of propofol ketamine mixture ( 10 mg/ml each) was applied in group II. Core body temperatures were taken before and after MRI and compared.
Participant Groups
-
body core temperature was measured from tympanic membrane after 1 mg/kg propofol administration, before and after magnetic resonance imaging
-
body core temperature was measured from tympanic membrane after 0,1 ml/kg administration of ketamine propofol mixture of 10 mg/ml both, before and after magnetic resonance imaging
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 1 |
Maximum Age: | 10 |
Age Groups: | Child |
Healthy Volunteers: | Yes |
Inclusion Criteria:
* children aged between 6 months-10 years,
* underwent MRI under anesthesia
* ASA I-II
Exclusion Criteria:
* History of drug allergy
* Severe pulmonary and cardiac disease
* Intracranial hypertension
* children aged between 6 months-10 years,
* underwent MRI under anesthesia
* ASA I-II
Exclusion Criteria:
* History of drug allergy
* Severe pulmonary and cardiac disease
* Intracranial hypertension
Primary Outcomes
More Details
NCT Number: | NCT02931786 |
---|---|
Other IDs: | 118099 |
Study URL: | https://clinicaltrials.gov/study/NCT02931786 |
Last updated: Sep 29, 2023